dc.contributor.author | Meyer, Aaron Samuel | |
dc.contributor.author | Zweemer, Jacomina M. | |
dc.contributor.author | Lauffenburger, Douglas A | |
dc.date.accessioned | 2017-02-15T21:31:26Z | |
dc.date.available | 2017-02-15T21:31:26Z | |
dc.date.issued | 2015-07 | |
dc.date.submitted | 2015-05 | |
dc.identifier.issn | 2405-4712 | |
dc.identifier.uri | http://hdl.handle.net/1721.1/106949 | |
dc.description.abstract | The AXL receptor is a TAM (Tyro3, AXL, MerTK) receptor tyrosine kinase (RTK) important in physiological inflammatory processes such as blood clotting, viral infection, and innate immune-mediated cell clearance. Overexpression of the receptor in a number of solid tumors is increasingly appreciated as a key drug resistance and tumor dissemination mechanism. Although the ligand-receptor (Gas6-AXL) complex structure is known, literature reports on ligand-mediated signaling have provided conflicting conclusions regarding the influence of other factors such as phosphatidylserine binding, and a detailed, mechanistic picture of AXL activation has not emerged. Integrating quantitative experiments with mathematical modeling, we show here that AXL operates to sense local spatial heterogeneity in ligand concentration, a feature consistent with its physiological role in inflammatory cell responses. This effect arises as a result of an intricate reaction-diffusion interaction. Our results demonstrate that AXL functions distinctly from other RTK families, a vital insight for the envisioned design of AXL-targeted therapeutic intervention. | en_US |
dc.description.sponsorship | National Institutes of Health (U.S.) (Grants U54-CA112967 and DP5-OD019815) | en_US |
dc.description.sponsorship | United States. Army Research Office (Institute for Collaborative Biotechnologies. Grant W911NF-09-0001) | en_US |
dc.description.sponsorship | National Cancer Institute (David H. Koch Institute for Integrative Cancer Research at MIT. Core Support Grant P30-CA14051) | en_US |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.relation.isversionof | http://dx.doi.org/10.1016/j.cels.2015.06.002 | en_US |
dc.rights | Creative Commons Attribution-NonCommercial-NoDerivs License | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | en_US |
dc.source | PMC | en_US |
dc.title | The AXL Receptor Is a Sensor of Ligand Spatial Heterogeneity | en_US |
dc.type | Article | en_US |
dc.identifier.citation | Meyer, Aaron S., Annelien J.M. Zweemer, and Douglas A. Lauffenburger. “The AXL Receptor Is a Sensor of Ligand Spatial Heterogeneity.” Cell Systems 1.1 (2015): 25–36. | en_US |
dc.contributor.department | Massachusetts Institute of Technology. Department of Biological Engineering | en_US |
dc.contributor.department | Koch Institute for Integrative Cancer Research at MIT | en_US |
dc.contributor.mitauthor | Meyer, Aaron Samuel | |
dc.contributor.mitauthor | Zweemer, Jacomina M. | |
dc.contributor.mitauthor | Lauffenburger, Douglas A | |
dc.relation.journal | Cell Systems | en_US |
dc.eprint.version | Author's final manuscript | en_US |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
dspace.orderedauthors | Meyer, Aaron S.; Zweemer, Annelien J.M.; Lauffenburger, Douglas A. | en_US |
dspace.embargo.terms | N | en_US |
dc.identifier.orcid | https://orcid.org/0000-0002-3539-3129 | |
mit.license | PUBLISHER_CC | en_US |
mit.metadata.status | Complete | |